Walking the path of
progress in healthcare
A record of continuous growth and unceasing challenges — that is the history of DaehanNupharm.
R&D Centered
2020 s
- 2024
-
-
06Launched DH Fuzole Tab, the world’s first
fluconazole formulation for companion dogs -
05Began construction of a new plant
-
- 2023
-
-
12Launched Rapiduo, a treatment for gastroesophageal
reflux disease -
06Completed construction of the research building
-
01Launched Dr. DiNU, a health functional food brand
exclusive for hospitals and clinics
-
- 2022
-
-
05Launched companion animal brand DiAnge
-
03Unveiled new CI (Corporate Identity)
-
- 2021
-
-
08Launched health functional food brand Dr. DiNU
-
04Completed construction of the Industry-AcademeResearch Center
-
Business Diversification
2010 s
- 2017
-
-
11Tambutine Tabed as one of the Top 3 medicines in Russia for two consecutive years
-
- 2016
-
-
10Initiated the new forage business
-
- 2015
-
-
12Awarded the “USD 10 Million Export Tower” award
-
07Opened the Bio Research Institute
-
- 2014
-
-
04Completed construction of a cell culture medium production plant
-
- 2012
-
-
10Launched new business in bio-process materials sales
-
Initial Public Offering (IPO)
2000 s
- 2007
-
-
11Awarded the “USD 5 Million Export Tower” award
-
06Overseas investment in oil field development in Kazakhstan
-
- 2002
-
-
07Designated as a “Promising Export SME”
-
02Listed on KOSDAQ
-
- 2001
-
-
12Acquired KVGMPapproval for veterinary medicines
-
06Established the Central Research Institute
-
04Changed corporate name to Daehan Nupharm Co.,
Ltd.
-
Entered the pharmaceutical business
1990 s
- 1996
-
-
06Obtained KGMP approval for oral solid dosage forms
-
- 1994
-
-
06Established the Hyangnam plant for entry into human pharmaceuticals
-
Built business infrastructure
1980 s
- 1984
-
-
12Obtained import/export license for veterinary medicines
-
10Licensed for manufacturing customized feed additives
-
10Founded Daehan Shin Yak Co.
-


Home